Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: J Neurooncol. 2010 Sep 2;103(2):197–206. doi: 10.1007/s11060-010-0378-3

Fig. 1.

Fig. 1

Endogenously synthesized β2m is not required for open conformer-dependent signaling in DAOY cells. a DAOY cells were treated with either β2m-specific siRNA or random siRNA control. Exogenous β2m was added 48 h later and lysates were subjected to the Western blot analysis using β2m- or GAPDH-specific antibodies, as indicated. b DAOY cells treated in the same manner as in a were stained with W6/32 (green lines; right), HC-10 (blue lines; middle) monoclonal antibodies, or secondary antibody alone (red lines; left), and analyzed by flow cytometry. c Exogenous β2m in the absence or presence of W6/32 (W) or HC-10 (H) monoclonal antibodies was added to DAOY cells pretreated with β2m-specific siRNA, as indicated. Cell lysates were probed by β2m-, GAPDH-, phospho-ERK1/2, or total ERK1/2-specific antibodies. C-control cells treated with neither siRNA nor exogenous β2m